Biblio Discovery — Demo Discovery Service

3 results for "Jared Mathai"

Showing 1–3 · 0.59 seconds · RSS

  1. Journal Article

    Sunitinib-Induced Adrenal Crisis in a Patient with Pre-Existing Immunotherapy-Related Hypopituitarism

    Anadil Javaid; Jared Mathai; David Song et al.

    Case Reports in Oncology, Vol. 15 No. 1 · 2022 · English · DOAJ Scopus

    Sunitinib is a tyrosine kinase inhibitor that is frequently used in the treatment of metastatic renal cell carcinoma (mRCC). As a multikinase inhibitor, numerous off-target side effects of this medication are widely recognized. More recently, endocrine side effects, including hypoadrenalism, are…

  2. Journal Article

    Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy

    Yang Wang, M.B.B.S.; Jared Mathai, M.B.B.S.; Muhammad Alamgeer, M.B.B.S., DMedSci et al.

    JTO Clinical and Research Reports, Vol. 4 No. 8 · 2023 · English · DOAJ Scopus

    Introduction: There are no clinically validated prognostic biomarkers in the management of extensive-stage SCLC (ES-SCLC). We explored the association between clinical characteristics and survival outcomes in patients with ES-SCLC treated with chemoimmunotherapy. Methods: In this retrospective…

  3. Journal Article

    Exercise Behaviors and Fatigue in Patients Receiving Immunotherapy for Advanced Melanoma: A Cross-Sectional Survey via Social Media

    Amelia Hyatt BA (hons); Allison Drosdowsky BA, BSci, MPH; Narelle Williams RN, MPH et al.

    Integrative Cancer Therapies, Vol. 18 · 2019 · English · DOAJ Scopus

    Objective: Treatment with immunotherapy has positively changed the long-term outlook of many patients with advanced melanoma; however, fatigue is a common and debilitating side effect. Evidence indicates exercise can improve treatment-related fatigue for patients receiving chemotherapy and…